Streetbeat News

Stock Prices

BTAI

BioXcel Therapeutics (NASDAQ:BTAI) has received 5 bullish and 3 indifferent analyst ratings in the last quarter. The average price target is $31.25, representing a significant upside from the current price of $4.33. However, this target is a 35.79% decrease from the previous average price target of $48.67.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

SOLO

Trading of Electrameccanica Vehicles' shares has resumed.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 1:00 pm

TSVT

In the last quarter, 2seventy bio (NASDAQ:TSVT) received 5 analyst ratings, with 1 being bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $22.0, representing an upside from the current price of $6.03. However, this average price target is a 16.98% decrease from the previous average price target of $26.50.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

TDG

TransDigm Gr (NYSE:TDG) has received mostly bullish ratings from analysts in the last quarter, with a total of 4 bullish, 3 somewhat bullish, and 2 indifferent ratings. The company's average price target is $981.67, which has increased by 8.59% over the past month.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

IP

SMG

SXC

Three materials stocks with over 4% dividend yields have been highlighted by Wall Street's most accurate analysts. These include International Paper Company (IP), The Scotts Miracle-Gro Company (SMG), and SunCoke Energy, Inc. (SXC). Recent analyst ratings and price targets for these stocks have been provided, along with their recent financial performance.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 1:00 pm

AAMC

Altisource Asset Management reported its Q2 financial results, which led to a decrease in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:58 pm

QQQ

SPY

US retail sales in July 2023 grew by 0.7% month-on-month, surpassing the expected 0.4% increase. This marks the fourth consecutive month of growth. Nonstore retailers led the growth with a 1.9% surge. However, motor vehicle and parts dealers saw a 0.3% decline. The market reacted with a brief spike in the dollar before it fell back, and stocks are set for a weak opening. S&P 500 index futures are 0.7% lower, while Nasdaq 100 futures are 0.6% lower. The SPDR S&P 500 ETF Trust (NYSE:SPY) rose 0.55%, while the Invesco QQQ Trust (NASDAQ:QQQ) was up 1.12%.

Portfolio Pulse from Piero Cingari

August 15, 2023 | 12:57 pm

PFE

The FDA has granted accelerated approval to Pfizer's Elrexfio, a therapy for adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. The approval is based on Phase 2 trial results and is contingent upon verification of clinical benefit in confirmatory trials. Pfizer expects the therapy to generate more than $4 billion in potential peak revenue. Pfizer's shares are down 0.42% in premarket trading.

Portfolio Pulse from Vandana Singh

August 15, 2023 | 12:56 pm

DCTH

Delcath Systems has received FDA approval for its HEPZATO KIT, a treatment for adult patients with unresectable hepatic-dominant metastatic uveal melanoma. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:56 pm

SPY

The USA Redbook Year-over-Year (YoY) has increased to 0.7% from the previous 0.3%.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 12:56 pm